scispace - formally typeset
Open AccessJournal ArticleDOI

Chemotaxis in cancer

TLDR
This Review summarizes how chemotaxis directs the different behaviours of tumour cells and stromal cells in vivo, how molecular pathways regulateChemotaxis in tumours and how chemtaxis choreographs cell behaviour to shape the tumour microenvironment and to determine metastatic spread.
Abstract
Chemotaxis of tumour cells and stromal cells in the surrounding microenvironment is an essential component of tumour dissemination during progression and metastasis. This Review summarizes how chemotaxis directs the different behaviours of tumour cells and stromal cells in vivo, how molecular pathways regulate chemotaxis in tumour cells and how chemotaxis choreographs cell behaviour to shape the tumour microenvironment and to determine metastatic spread. The central importance of chemotaxis in cancer progression is highlighted by discussion of the use of chemotaxis as a prognostic marker, a treatment end point and a target of therapeutic intervention.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Directed migration of mesenchymal cells: where signaling and the cytoskeleton meet

TL;DR: The emerging hypothesis is that the molecular underpinnings of mesenchymal taxis involve distinct signaling pathways and diverse requirements for regulation.

Tumor cell migration in complex microenvironments

TL;DR: The factors that influence tumor cell migration are discussed with a focus on the migration of transformed carcinoma cells and the development of new assays capable of applying multiple, simultaneous stimuli and imaging the cellular migratory response in real-time are focused on.
Journal ArticleDOI

Chemotaxis-Guided Hybrid Neutrophil Micromotors for Targeted Drug Transport

TL;DR: The studies suggest that this camouflaging approach, which favors the uptake of MSNs into neutrophils without loss of cellular activity and motility, could be used to construct synthetic nanoparticle-loaded biohybrid micromotors for advanced biomedical applications.
Journal ArticleDOI

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors.

TL;DR: Under the pressure applied by anti-PD1/PDL1 therapy, tumors experience immunoediting and preserve beneficial mutations, upregulate the compensatory inhibitory signaling and induce re-ex exhaustion of T cells, all of which may attenuate the durability of the therapy.
Journal ArticleDOI

α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration

TL;DR: A tight correlation between acetylated α-tubulin levels and aggressive metastatic behavior in breast cancer is identified, with potential implications for the definition of a simple prognostic biomarker in patients with breast cancer.
References
More filters
Journal ArticleDOI

Epithelial-Mesenchymal Transitions in Development and Disease

TL;DR: The mesenchymal state is associated with the capacity of cells to migrate to distant organs and maintain stemness, allowing their subsequent differentiation into multiple cell types during development and the initiation of metastasis.
Journal ArticleDOI

Myeloid-derived suppressor cells as regulators of the immune system.

TL;DR: The origin, mechanisms of expansion and suppressive functions of MDSCs, as well as the potential to target these cells for therapeutic benefit are discussed.
Journal ArticleDOI

Involvement of chemokine receptors in breast cancer metastasis.

TL;DR: It is reported that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases and their respective ligands CXCL12/SDF-1α and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis.
Related Papers (5)
Trending Questions (2)
What part of chemotaxis in cancer has not been studied yet?

The text does not provide information about any specific part of chemotaxis in cancer that has not been studied yet.

What part of chemotaxis in breast cancer has not been studied yet?

The specific part of chemotaxis in breast cancer that has not been studied yet is not mentioned in the provided information.